Analystreport

Harpoon Therapeutics, Inc. (NASDAQ: HARP) had its "buy" rating re-affirmed by analysts at SVB Leerink LLC.

Harpoon Therapeutics, Inc.  (HARP) 
Last harpoon therapeutics, inc. earnings: 3/12 04:05 pm Check Earnings Report